Scene dance poem recitation dedicated to the world scenery
Release time:
2020-08-14
Scene Dance Poetry Recitation Dedicated to World Scenery
Performance Unit: Daye Peak Cement Company
Female :
No matter when
No matter what venue
Speaking of you
, we seem to enjoy a scenery
breathtaking
female 2 :
seems to look up at a high mountain
standing tall
you cast the glory and happiness of others
women together:
You bring this world
Forever Fixation of Beauty
Male 1 :
I came from the mountain
with the backbone of the mountain
I came out of the fire
to write the legend of kiln fire
female 2 :
I stare at you-
You decorate yourself with the colors of mountains and fire
Male 2 :
but actually
such colors
are not my primary colors
that are sweat drops reflecting seven colors of light
female 1 :
I see your blood vessels running with bright red passion
I see your eyes shining with dark blue intelligence
male 1 :
My name is Peak
Always Look at the Sky
Male 2 :
My name is Peak
Always Step on the Earth
at the Foot
Cyan is My Bottom Color
in Front
Dream is My Deep Theme
Male 1 :
I have calcined all the stories
into colorful colors
male 2 :
standing I am a tall building
embracing blue sky
male 1 :
Lying I am all roads
Nestled Earth
Female 1 :
I touch you-
seems to be turning over a thick diary
"create the greatest value for customers"
write on your cover
"users' complaints about product quality are zero"
is your back cover
male 2 :
has determined the quality policy
from now on us
to make every effort to work hard
to hold the lifeblood of quality
tightly in hand
male 1 :
"the next process is the customer"
we make everything
more refined
female 1 :
I listen to you-
your story is strange and familiar with
female 2 :
"Concrete Laboratory"
Improve the Ability of Enterprises to Serve the Market
"Technician Innovation Studio"
Make Innovation a Brave Game
Male 2 :
Building Platform Providing Funds
Research Technology Strive for the Day
Male 1 :
is just 2017
that 20 many technological transformations
has turned into real benefits
male 2 :
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31